Professor Bellgrove has been at the forefront of international efforts to identify objective and quantifiable indices of genetic risk, termed endophenotypes, for ADHD. His early work identified reliable linkages between catecholamine risk genes for ADHD and distinct neurocognitive profiles. This work was published in high impact journals, has attracted high citations and continues to be influential in shaping the way the field approaches the issue of clinical and aetiological heterogeneity that besets psychiatric genetics. With papers in top-tier journals including Molecular Psychiatry, Nature Neuroscience and the Journal of Neuroscience, Professor Bellgrove is a recognized international expert on the molecular genetics of attention and attention deficit. The research achievements of Professor Bellgrove have been recognized with awards from NARSAD (USA), the Academy of Social Sciences in Australia and Biological Psychiatry Australia. His programme of research is funded by both the National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC). He is currently a Future Fellow of the ARC.